Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Vaccines

Free Subscription 27.04.2026 2 BMJ 1 Infect Immun 1 J Immunol 3 J Infect Dis 4 J Virol 1 JAMA 1 MMWR Morb Mortal Wkly Rep 1 N Engl J Med 1 Nat Immunol 1 Pediatr Infect Dis J 1 Pediatrics 3 PLoS One 22 Vaccine 1 Virology 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. WISE J
   Bird flu: mRNA vaccine trial begins in UK.
   BMJ. 2026;393:s759.
   PubMed        
   
   
2. WISE J
   RSV: Maternal vaccine cuts infant hospital admissions by 80%, study shows.
   BMJ. 2026;393:s752.
   PubMed        
   
   

   
   Infect Immun

3. GARNICA O, Veerapandian R, Das K, Mishra A, et al
   Construction and characterization of novel Mycobacterium tuberculosis-derived triple and quadruple knockout vaccines against tuberculosis.
   Infect Immun. 2026 Apr 21:e0050025. doi: 10.1128/iai.00500.
   PubMed         Abstract available
   
   

   
   J Immunol

4. YU H, Geisler WM, Dai C, Sabbaj S, et al
   Immunological evaluation of vaccines to prevent Chlamydia trachomatis infection using the human in vitro MIMIC system.
   J Immunol. 2026;215:vkag080.
   PubMed         Abstract available
   
   

   
   J Infect Dis

5. NORONHA IH, Wada LN, Rossetto BS, Moraschi BF, et al
   "Intranasal vaccination with recombinant human adenovirus encoding the trans-sialidase gene protects mice from lethal subcutaneous and oral Trypanosoma cruzi trypomastigote challenges".
   J Infect Dis. 2026 Apr 23:jiag227. doi: 10.1093.
   PubMed         Abstract available
   
   
6. WALKER R, Choy RKM
   Shigella Vaccines: A light at the end of a long tunnel.
   J Infect Dis. 2026 Apr 23:jiag221. doi: 10.1093.
   PubMed        
   
   
7. CHEN WH, Barry EM, Toapanta FR, Pasetti MF, et al
   First-in-Human Evaluation of the Safety, Genetic Stability, and Immunogenicity of an Attenuated Shigella flexneri 2a Live Vector Expressing Enterotoxigenic Escherichia coli Antigens, Vaccine Strain CVD 1208S-122.
   J Infect Dis. 2026 Apr 18:jiag220. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Virol

8. CHENG X, Deng H, Bian X, Wang J, et al
   Simultaneous expression of three G genotypes of VP7 proteins in a recombinant porcine rotavirus confers protective immunity against multiple rotavirus infections.
   J Virol. 2026;100:e0201525.
   PubMed         Abstract available
   
   
9. SONI S, Eertink LG, Shuisong N, Loynachan A, et al
   Cross-neutralization and antigenic characterization of simian and equine group A rotaviruses.
   J Virol. 2026;100:e0019926.
   PubMed         Abstract available
   
   
10. SINGH S, Kumar S, Luthra K
    Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response.
    J Virol. 2026 Apr 21:e0220225. doi: 10.1128/jvi.02202.
    PubMed         Abstract available
    
    
11. YANG M, Zhao Y, Guo W, Wang L, et al
    Development of a vaccine based on mRNA assembly of PEDV virus-like particle.
    J Virol. 2026 Apr 21:e0206025. doi: 10.1128/jvi.02060.
    PubMed         Abstract available
    
    

    
    JAMA

12. KUKOYI OM, Wang VS, Yao K, Cipriano CB, et al
    US State Actions Related to COVID-19 Vaccination Infrastructure and Access Amid Federal Shifts.
    JAMA. 2026 Apr 20:e265148. doi: 10.1001/jama.2026.5148.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

13. BELL JM, Barbre K, Meng L, Lape-Newman B, et al
    Influenza Vaccination Coverage Among Nursing Home Residents and Health Care Personnel - United States, 2024-25 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2026;75:195-201.
    PubMed         Abstract available
    
    

    
    N Engl J Med

14. BUTLER CC, Pinto AD, Harris V, Holmes J, et al
    Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.
    N Engl J Med. 2026;394:1583-1594.
    PubMed         Abstract available
    
    

    
    Nat Immunol

15. JENKINS RG
    Developing a vaccine strategy to prevent the progression of pulmonary fibrosis.
    Nat Immunol. 2026 Apr 20. doi: 10.1038/s41590-026-02487.
    PubMed        
    
    

    
    Pediatr Infect Dis J

16. MIURA H, Manabe M, Ihira M, Kozawa K, et al
    Safety of Rotavirus Vaccination in a Growing Care Unit (Intermediate-care Neonatal Unit) in Japan.
    Pediatr Infect Dis J. 2026 Apr 22. doi: 10.1097/INF.0000000000005251.
    PubMed         Abstract available
    
    

    
    Pediatrics

17. JACOBSON KB, Merchant M, Fireman B, Klein NP, et al
    SARS-CoV-2 Vaccination Before and During Pregnancy and Prevention of Infant COVID-19 Infection.
    Pediatrics. 2026 Apr 22:e2025073000. doi: 10.1542/peds.2025-073000.
    PubMed         Abstract available
    
    

    
    PLoS One

18. IPEKCI AM, Hodel EM, Filsinger M, Wegmuller S, et al
    Who would take part in a pandemic preparedness cohort study? The role of vaccine-related affective polarisation: Cross-sectional survey.
    PLoS One. 2026;21:e0346420.
    PubMed         Abstract available
    
    
19. LEE J, Bajiya VP, Jung E
    Vaccination scenario-based study on seasonal influenza in Republic of Korea.
    PLoS One. 2026;21:e0322686.
    PubMed         Abstract available
    
    
20. MCDONALD C, Grajales AG, Yahia NA, Fisman D, et al
    Healthcare resource utilization and cost burden of COVID-19 according to vaccination status in adults in Ontario, Canada, 2021-2023.
    PLoS One. 2026;21:e0344690.
    PubMed         Abstract available
    
    

    
    Vaccine

21. GOTHAM D, Frick M, Harrington M
    Understanding adjuvant supply chains for new TB and malaria vaccines.
    Vaccine. 2026;82:128609.
    PubMed        
    
    
22. LUNDGREN A, Vannice K, Ryan E, Steele D, et al
    Improving cholera vaccination impact through advances in gut mucosal immunology: outcomes of a 2025 expert consultation.
    Vaccine. 2026;81:128571.
    PubMed         Abstract available
    
    
23. WANG X, Wu T
    Advancements in therapeutic HBV vaccines: navigating the path toward functional cure.
    Vaccine. 2026;82:128610.
    PubMed         Abstract available
    
    
24. LU Q, Peng Y, Dong Z, Luo S, et al
    MlaA, a conserved outer membrane protein of Neisseria gonorrhoeae, elicits potent functional immunity and protects against vaginal infection as a mucosal vaccine candidate.
    Vaccine. 2026;82:128625.
    PubMed         Abstract available
    
    
25. SHAPIRO I, Tadese BK, Hoshen M, Chen YT, et al
    A significant decrease in anogenital warts incidence following the implementation of a national human papillomavirus immunization program in Israel.
    Vaccine. 2026;80:128516.
    PubMed         Abstract available
    
    
26. LORENZO JC, Islam MI, Mathieu E
    Exploring socio-economic inequalities in measles immunisation in Lao People's Democratic Republic, Thailand, and Viet Nam.
    Vaccine. 2026;80:128507.
    PubMed         Abstract available
    
    
27. ZRIBA S, Niroula N, McDonald S, Whitecross D, et al
    Recombinant Mycobacterium smegmatis producing a functional M. tuberculosis ESX-1 system is protective in the murine model of bovine TB without sensitization to tuberculin.
    Vaccine. 2026;80:128545.
    PubMed         Abstract available
    
    
28. QUINTANAR-SOLARES M, Fleming JA, Musau W, Mulati F, et al
    RSV ready? Exploring feasibility and acceptability of RSV immunization options in low- and middle-income countries.
    Vaccine. 2026;80:128550.
    PubMed         Abstract available
    
    
29. KITANO T, Hashimoto E, Sado T, Yoshida S, et al
    Maternal effectiveness of respiratory syncytial virus using multicenter healthcare records: A retrospective cohort study.
    Vaccine. 2026;80:128566.
    PubMed         Abstract available
    
    
30. CORTES FH, Agarwal R, Ha C, Escarrega EA, et al
    Chikungunya virus virus-like particle vaccine (Vimkunya) induces a rapid and durable antigen-specific CD4(+) T cell response.
    Vaccine. 2026;82:128548.
    PubMed         Abstract available
    
    
31. VANDE HEY JM, Ward D, Buys A, Caldera F, et al
    Hepatitis B challenge dose in vaccinated healthcare personnel susceptible at hire.
    Vaccine. 2026;82:128589.
    PubMed         Abstract available
    
    
32. ZHANG L, Lin T, Wang M, Ma X, et al
    Effectiveness of prescription-based influenza vaccination services among older adults in Binzhou, China: A cluster-randomized controlled trial.
    Vaccine. 2026;82:128588.
    PubMed         Abstract available
    
    
33. FOLEGATTI PM, Pepin S, Tabar C, Fries K, et al
    Immunogenicity and safety of recombinant influenza vaccine versus standard inactivated influenza vaccine in children aged 3 to 8 years: results from a phase III randomised study.
    Vaccine. 2026;82:128582.
    PubMed         Abstract available
    
    
34. CANACA G, Vicuna B, Hess JM, Cruz TH, et al
    From engagement to ownership: a qualitative study of a community-academic partnership to promote COVID-19 vaccine confidence among Latino/Hispanic communities in New Mexico.
    Vaccine. 2026;60 Suppl 1:128583.
    PubMed         Abstract available
    
    
35. SABAHELZAIN MM, Tinessia A, King C, Nepali R, et al
    Joint human and animal vaccination strategies to reach mobile pastoralists and their livestock in Africa: A scoping review.
    Vaccine. 2026;81:128594.
    PubMed         Abstract available
    
    
36. GULATI RR, Yaqub F, Goodman AL
    Enhancing uptake of respiratory vaccinations in asthma and chronic obstructive pulmonary disease (COPD) patients: a systematic review.
    Vaccine. 2026;81:128560.
    PubMed         Abstract available
    
    
37. OMAZIC A, Guo J
    Tick-borne encephalitis vaccination coverage among outdoor workers in Sweden: a nationwide survey.
    Vaccine. 2026;82:128593.
    PubMed         Abstract available
    
    
38. PAUL KK, Torres M, Shih STF, Gray RT, et al
    Estimating the cost-effectiveness of respiratory syncytial virus (RSV) vaccination program for older Australian adults.
    Vaccine. 2026;82:128591.
    PubMed         Abstract available
    
    
39. MORENO MZ, Prada MF, Gonzalez PC, Gomariz AM, et al
    Safety of the adjuvanted herpes zoster subunit vaccine in people over 18 years of age living with HIV: A phase 4 multicentre study.
    Vaccine. 2026;82:128581.
    PubMed         Abstract available
    
    
40. SKRIP L, Hidano A, Poovorawan Y, Khongwichit S, et al
    Vaccine value profile for severe fever with thrombocytopenia syndrome (SFTS).
    Vaccine. 2026;82:128596.
    PubMed         Abstract available
    
    
41. SARNAIK AY, Khan ZU, Rajeswaran T, Majoe A, et al
    The role of misinformation in COVID-19 vaccine hesitancy in low- & middle-income countries.
    Vaccine. 2026;82:128595.
    PubMed         Abstract available
    
    
42. KUHLMEY E, Polavarapu T, Semprini J, Reimer RA, et al
    State minor consent laws and human papilloma virus vaccine uptake: An analysis of the 2023 National Immunization Survey-Teen Data.
    Vaccine. 2026;82:128598.
    PubMed         Abstract available
    
    

    
    Virology

43. BUDE SA, Zhao Z, Zhang J, Lu Z, et al
    Expression of pseudorabies virus glycoproteins E and B based on vaccinia virus.
    Virology. 2026;620:110916.
    PubMed         Abstract available
    
    

    
    Virus Res

44. FARSIU N, Mahani FK, Arefinia N, Charostad J, et al
    From Legacy to Innovation: A Comprehensive Review of Vaccine Platforms Against Viral Infections.
    Virus Res. 2026 Apr 16:199730. doi: 10.1016/j.virusres.2026.199730.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum